These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 2207701)

  • 21. Involvement of 5-HT2 receptors in the behaviours produced by intrathecal administration of selected 5-HT agonists and the TRH analogue (CG 3509) to rats.
    Fone KC; Johnson JV; Bennett GW; Marsden CA
    Br J Pharmacol; 1989 Mar; 96(3):599-608. PubMed ID: 2470455
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effect of 5,7-dihydroxytryptamine on serotonergic control of prolactin secretion and behavior in rats.
    Kuhn CM; Vogel RA; Mailman RB; Mueller RA; Schanberg SM; Breese GR
    Psychopharmacology (Berl); 1981; 73(2):188-93. PubMed ID: 6785814
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Codepletion of serotonin and TRH induces apparent supersensitivity of spinal TRH receptors.
    Sharif NA; Burt DR; Towle AC; Mueller RA; Breese GR
    Eur J Pharmacol; 1983 Nov; 95(3-4):301-4. PubMed ID: 6317416
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The guinea pig myoclonic model: behavioral supersensitivity to 5-hydroxytryptophan induced by intracisternal 5,7-dihydroxytryptamine.
    Pranzatelli MR; Snodgrass SR
    Eur J Pharmacol; 1987 Nov; 143(2):237-42. PubMed ID: 3500866
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Developmental changes in serotonin and 5-hydroxyindoleacetic acid concentrations and opiate receptor binding in rat spinal cord following neonatal 5,7-dihydroxytryptamine treatment.
    Kirby ML; Mattio TG
    Dev Neurosci; 1982; 5(5-6):394-402. PubMed ID: 6186451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential radioligand binding properties of [3H]5-hydroxytryptamine and [3H]mesulergine in a clonal 5-hydroxytryptamine1C cell line.
    Havlik S; Peroutka SJ
    Brain Res; 1992 Jul; 584(1-2):191-6. PubMed ID: 1515938
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Alterations in serotonin binding sites after 5,7-dihydroxytryptamine treatment in the rat spinal cord.
    Brown LM; Smith DL; Williams GM; Smith DJ
    Neurosci Lett; 1989 Jul; 102(1):103-7. PubMed ID: 2779841
    [TBL] [Abstract][Full Text] [Related]  

  • 28. p,p'-DDT myoclonic/epileptic model: serotonin receptor binding and behavioral studies in the rat.
    Pranzatelli MR; Tailor PT; Pluchino R; Gonzales W; Simmens S
    Neurotoxicology; 1994; 15(2):261-72. PubMed ID: 7991214
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Identification of 5-hydroxytryptamine binding site subtypes in rat spinal cord.
    Huang JC; Peroutka SJ
    Brain Res; 1987 Dec; 436(1):173-6. PubMed ID: 2961414
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Differential effects of chronic antidepressant treatment on 5-HT1C receptor binding sites in Wistar rat brain.
    Hulihan-Giblin BA; Park YD; Aulakh CS
    Eur J Pharmacol; 1994 Sep; 263(1-2):213-6. PubMed ID: 7821356
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Distribution of the 5-hydroxytryptamine2C receptor protein in adult rat brain and spinal cord determined using a receptor-directed antibody: effect of 5,7-dihydroxytryptamine.
    Sharma A; Punhani T; Fone KC
    Synapse; 1997 Sep; 27(1):45-56. PubMed ID: 9268064
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Regional differences in the ontogeny of 5-hydroxytryptamine-1C binding sites in rat brain and spinal cord.
    Pranzatelli MR
    Neurosci Lett; 1993 Jan; 149(1):9-11. PubMed ID: 8469389
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Enhanced quinpirole response in rats lesioned neonatally with 5,7-dihydroxytryptamine.
    Brus R; Plech A; Kostrzewa RM
    Pharmacol Biochem Behav; 1995 Apr; 50(4):649-53. PubMed ID: 7617714
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MK-212 increases rat plasma ACTH concentration by activation of the 5-HT1C receptor subtype.
    King BH; Brazell C; Dourish CT; Middlemiss DN
    Neurosci Lett; 1989 Oct; 105(1-2):174-6. PubMed ID: 2562060
    [TBL] [Abstract][Full Text] [Related]  

  • 35. 1-5-Hydroxytryptophan-induced flat body posture in the rat: antagonism by ritanserin and potentiation after 5,7-dihydroxytryptamine.
    Colpaert FC; Koek W; Lategan A
    Eur J Pharmacol; 1989 Oct; 169(1):175-8. PubMed ID: 2513211
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effects of 5-HT receptor subtype-selective drugs on locomotor activity and motor habituation in the DHT adult rat model.
    Pranzatelli MR; Jappay E; Snodgrass SR
    Pharmacol Biochem Behav; 1987 Jul; 27(3):497-504. PubMed ID: 3116560
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Behavioral and prolactin responses to 5-hydroxytryptophan in rats treated during development with 5,7-dihydroxytryptamine.
    Breese GR; Vogel RA; Kuhn CM; Mailman RB; Mueller RA; Schanberg SM
    Brain Res; 1978 Oct; 155(2):263-75. PubMed ID: 308387
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alterations in 8-hydroxy-2-(dipropylamino)tetralin-induced neuroendocrine responses after 5,7-dihydroxytryptamine-induced denervation of serotonergic neurons.
    Van de Kar LD; Li Q; Cabrera TM; Brownfield MS; Battaglia G
    J Pharmacol Exp Ther; 1998 Jul; 286(1):256-62. PubMed ID: 9655867
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [125I]LSD labels 5-HT1C recognition sites in pig choroid plexus membranes. Comparison with [3H]mesulergine and [3H]5-HT binding.
    Hoyer D; Srivatsa S; Pazos A; Engel G; Palacios JM
    Neurosci Lett; 1986 Sep; 69(3):269-74. PubMed ID: 3763057
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Changes in sensitivity to intrathecal norepinephrine and serotonin after 6-hydroxydopamine (6-OHDA), 5,6-dihydroxytryptamine (5,6-DHT) or repeated monoamine administration.
    Howe JR; Yaksh TL
    J Pharmacol Exp Ther; 1982 Feb; 220(2):311-21. PubMed ID: 6120226
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.